News | September 12, 2014

Mevion Medical Systems Introduces Hyperscan for Mevion S250 Platform

September 12, 2014 — Mevion Medical Systems introduced Hyperscan for the Mevion S250 modular single-room proton therapy system. Benefiting from direct and efficient proton beam generation, Hyperscan’s patented technology allows radiation to be precisely delivered using a sharp beam of radiation, with the tumor being volumetrically scanned in a matter of seconds. Current pencil beam delivery systems are known to be sensitive to motion, which can result in higher treatment uncertainties. Hyperscan’s fast beam delivery is much less sensitive to patient and tumor motions, thus delivering a more robust treatment.

“Hyperscan enables treatment with fine precision at tremendous speed and with uncompromised beam quality,” said Joseph K. Jachinowski, president and CEO of Mevion Medical Systems. “This new technological advance will help providers deliver the best possible cancer care to the patients who need it most.”

Hyperscan is debuting at the 56th annual meeting of the American Society for Radiation Oncology (ASTRO), being held Sept. 14-16 in San Francisco. It is built on the Mevion S250 proton therapy platform that has been operating clinically since December 2013. The Hyperscan system features rapid volumetric and layer rescanning, a streamlined image-based clinical workflow, sub-millimeter position tracking and beam gating connectivity.

Simultaneously, Mevion is announcing it has reached an agreement with a financial services provider to offer financing to customers interested in purchasing the Mevion S250. This will provide Mevion’s customers with an alternative to traditional financing structures, should they desire it.

“The introduction of Hyperscan technology and the availability of alternative financing is a demonstration of Mevion’s continued commitment to improving the worldwide availability and clinical use of proton therapy,” said Jachinowski. “Mevion is dedicated to removing the obstacles of size, complexity and cost that exist with conventional proton therapy systems and making proton therapy as accessible as possible to the cancer patients who need it.”

The U.S. Food and Drug Administration (FDA) has not cleared Hyperscan for clinical use.

For more information:

Related Content

Sponsored Content | Videos | Proton Therapy | August 21, 2017
Mark Pankuch, Ph.D., director of medical physics at the Northwestern Medicine Chicago Proton Center, discusses the cl
MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
Eight Proton Therapy Centers Worldwide Adopt RayStation for Treatment Planning
News | Treatment Planning | July 21, 2017
RaySearch Laboratories reported that eight additional proton therapy centers worldwide have recently chosen RayStation...
IBA to Install Proton Therapy Facility at Inova Schar Cancer Institute
News | Proton Therapy | July 18, 2017
IBA (Ion Beam Applications S.A.) and Inova recently signed a contract for a two-room Proteus Plus proton therapy...
Proton International and Beaumont Health Open Michigan's First Proton Therapy Facility
News | Proton Therapy | July 17, 2017
Proton International (PI) and Beaumont Health recently opened the state’s first proton therapy center, offering the...
ASTRO Updates Insurance Coverage Recommendations for Proton Therapy
News | Proton Therapy | July 17, 2017
The American Society for Radiation Oncology (ASTRO) has issued an update to its recommendations for medical insurance...
IBA and Philips Step Up Commercial Collaboration in Brazilian Proton Therapy Market
News | Radiation Therapy | July 03, 2017
IBA and Philips announced in mid-June they are stepping up their combined effort for proton therapy in Brazil.
First Patient Treated With Pencil Beam Scanning at Institute Curie Proton Therapy Center
News | Proton Therapy | May 23, 2017
May 23, 2017 — IBA announced that the first patient has been treated with pencil beam scanning (PBS) technology at th
News | Radiation Therapy | May 16, 2017
Proton International announced the successful financing of a new state-of-the-art radiation therapy center and a...
Overlay Init